Trump Administration Takes Bold Step to Withdraw U.S. from World Health Organization

  President Donald J. Trump has signed an executive order initiating the withdrawal of the United States from the World Health Organization (WHO). Th...

January 21, 2025 | Tuesday | News
Sanofi’s Opella Achieves FDA Approval to Initiate OTC Cialis Use Trial

Opella, Sanofi’s Consumer Healthcare business, announced that the US Food and Drug Administration (FDA) has lifted a clinical hold on its planned a...

January 21, 2025 | Tuesday | News
Junshi Biosciences Partners with LEO Pharma to Launch Toripalimab in Europe

Shanghai Junshi Biosciences Co., Ltd , a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercializati...

January 21, 2025 | Tuesday | News
PharmAla Biotech Partners with Merhavim Mental Health Centre for Groundbreaking MDMA-Assisted Psychotherapy Trial

PharmAla Biotech Holdings Inc.  a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel deriv...

January 21, 2025 | Tuesday | News
Fermion and Simcere Partner to Advance Innovative SSTR4 Agonist for Pain Management in Greater China

Guangzhou Fermion Technology Co., Ltd. and Simcere Pharmaceutical Group Limited (HKEX: 2096) have announced a partnership to develop a clinical-stage pain ...

January 20, 2025 | Monday | News
Celltrion Unveils Innovative Drug Development Strategy at J.P. Morgan Healthcare Conference

Celltrion, Inc. (068270.KS), a leading global biopharmaceutical company,  announced its innovative drug development strategy in the rigorous and cutti...

January 15, 2025 | Wednesday | News
Samsung Biologics CEO John Rim Highlights 2025 Growth Strategy at J.P. Morgan Healthcare Conference

Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO),  announced its latest business achievements a...

January 15, 2025 | Wednesday | News
Telix Pharmaceuticals CEO to Present at 43rd Annual J.P. Morgan Healthcare Conference

Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) advises that Dr. Christian Behrenbruch, Managing Director and Group CEO, wil...

January 15, 2025 | Wednesday | News
Acadia Pharmaceuticals Highlights Strong Growth and Pipeline Advancements at J.P. Morgan Healthcare Conference

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) announced multiple business updates and progress on the Company's CNS and rare disease drug candidates, which wi...

January 15, 2025 | Wednesday | News
P3 Health Partners to Present at 2024 J.P. Morgan Healthcare Conference

P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management c...

January 15, 2025 | Wednesday | News
NVIDIA's CEO Jensen Huang Highlights AI Advancements in Healthcare at J.P. Morgan Conference

AI is making inroads across the entire healthcare industry — from genomic research to drug discovery, clinical trial workflows and patient care. I...

January 15, 2025 | Wednesday | News
Pfizer Announces Positive Phase 3 CREST Trial Results for Sasanlimab in High-Risk Non-Muscle Invasive Bladder Cancer

Clinically meaningful and statistically significant results are the first pivotal Phase 3 data for sasanlimab, a subcutaneously administered PD-1...

January 13, 2025 | Monday | News
Naveris Expands Commercial Availability of NavDx Test for HPV-Positive Anal Cancer, Enhancing MRD Detection

Naveris, Inc., the leader in precision oncology diagnostics for viral-induced cancers, today announced the expanded commercial availability of the NavDx ...

January 13, 2025 | Monday | News
Kardigan Launches with $300 Million Series A to Transform Cardiovascular Disease Treatment

Company embarks on a vision to make cardiovascular disease curable, preventable, and no longer the leading cause of death worldwide Led by found...

January 13, 2025 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close